Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 9(1): 4047, 2018 10 02.
Article in English | MEDLINE | ID: mdl-30279449

ABSTRACT

Recent reports suggest that induced neurons (iNs), but not induced pluripotent stem cell (iPSC)-derived neurons, largely preserve age-associated traits. Here, we report on the extent of preserved epigenetic and transcriptional aging signatures in directly converted induced neural stem cells (iNSCs). Employing restricted and integration-free expression of SOX2 and c-MYC, we generated a fully functional, bona fide NSC population from adult blood cells that remains highly responsive to regional patterning cues. Upon conversion, low passage iNSCs display a profound loss of age-related DNA methylation signatures, which further erode across extended passaging, thereby approximating the DNA methylation age of isogenic iPSC-derived neural precursors. This epigenetic rejuvenation is accompanied by a lack of age-associated transcriptional signatures and absence of cellular aging hallmarks. We find iNSCs to be competent for modeling pathological protein aggregation and for neurotransplantation, depicting blood-to-NSC conversion as a rapid alternative route for both disease modeling and neuroregeneration.


Subject(s)
Aging/genetics , Induced Pluripotent Stem Cells , Neural Stem Cells , Aging/metabolism , DNA Methylation , Epigenesis, Genetic , Humans , Machado-Joseph Disease/blood , Peripheral Blood Stem Cells
2.
PLoS Genet ; 12(1): e1005768, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26730850

ABSTRACT

The genome of the fission yeast Schizosaccharomyces pombe encodes 17 kinases that are essential for cell growth. These include the cell-cycle regulator Cdc2, as well as several kinases that coordinate cell growth, polarity, and morphogenesis during the cell cycle. In this study, we further characterized another of these essential kinases, Prp4, and showed that the splicing of many introns is dependent on Prp4 kinase activity. For detailed characterization, we chose the genes res1 and ppk8, each of which contains one intron of typical size and position. Splicing of the res1 intron was dependent on Prp4 kinase activity, whereas splicing of the ppk8 intron was not. Extensive mutational analyses of the 5' splice site of both genes revealed that proper transient interaction with the 5' end of snRNA U1 governs the dependence of splicing on Prp4 kinase activity. Proper transient interaction between the branch sequence and snRNA U2 was also important. Therefore, the Prp4 kinase is required for recognition and efficient splicing of introns displaying weak exon1/5' splice sites and weak branch sequences.


Subject(s)
Protein Serine-Threonine Kinases/genetics , RNA Splice Sites/genetics , RNA Splicing/genetics , Ribonucleoprotein, U4-U6 Small Nuclear/genetics , Schizosaccharomyces pombe Proteins/genetics , Schizosaccharomyces/genetics , Cell Cycle Proteins/genetics , Introns/genetics , Mutation , RNA Splicing Factors , Ribonucleoproteins, Small Nuclear/genetics , Spliceosomes/genetics , Transcription Factors/genetics
3.
Cell Mol Life Sci ; 73(10): 2089-104, 2016 May.
Article in English | MEDLINE | ID: mdl-26573968

ABSTRACT

Spinal muscular atrophy (SMA) is a devastating motoneuron (MN) disorder caused by homozygous loss of SMN1. Rarely, SMN1-deleted individuals are fully asymptomatic despite carrying identical SMN2 copies as their SMA III-affected siblings suggesting protection by genetic modifiers other than SMN2. High plastin 3 (PLS3) expression has previously been found in lymphoblastoid cells but not in fibroblasts of asymptomatic compared to symptomatic siblings. To find out whether PLS3 is also upregulated in MNs of asymptomatic individuals and thus a convincing SMA protective modifier, we generated induced pluripotent stem cells (iPSCs) from fibroblasts of three asymptomatic and three SMA III-affected siblings from two families and compared these to iPSCs from a SMA I patient and control individuals. MNs were differentiated from iPSC-derived small molecule neural precursor cells (smNPCs). All four genotype classes showed similar capacity to differentiate into MNs at day 8. However, SMA I-derived MN survival was significantly decreased while SMA III- and asymptomatic-derived MN survival was moderately reduced compared to controls at day 27. SMN expression levels and concomitant gem numbers broadly matched SMN2 copy number distribution; SMA I presented the lowest levels, whereas SMA III and asymptomatic showed similar levels. In contrast, PLS3 was significantly upregulated in mixed MN cultures from asymptomatic individuals pinpointing a tissue-specific regulation. Evidence for strong PLS3 accumulation in shaft and rim of growth cones in MN cultures from asymptomatic individuals implies an important role in neuromuscular synapse formation and maintenance. These findings provide strong evidence that PLS3 is a genuine SMA protective modifier.


Subject(s)
Membrane Glycoproteins/metabolism , Microfilament Proteins/metabolism , Motor Neurons/pathology , Muscular Atrophy, Spinal/genetics , Neural Stem Cells/cytology , Survival of Motor Neuron 1 Protein/genetics , Up-Regulation , Biopsy , Cell Differentiation , Female , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Deletion , Gene Silencing , Genetic Vectors , Genotype , Humans , Immunohistochemistry , Induced Pluripotent Stem Cells/cytology , Karyotyping , Lymphocytes/cytology , Male , Microscopy, Confocal , Mutation , Pedigree , Phenotype , RNA, Small Interfering/metabolism , Skin/pathology
4.
Stem Cell Rev Rep ; 11(4): 560-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25392050

ABSTRACT

Various strategies have been published enabling cardiomyocyte differentiation of human induced pluripotent stem (iPS) cells. However the complex nature of signaling pathways involved as well as line-to-line variability compromises the application of a particular protocol to robustly obtain cardiomyocytes from multiple iPS lines. Hence it is necessary to identify optimized protocols with alternative combinations of specific growth factors and small molecules to enhance the robustness of cardiac differentiation. Here we focus on systematic modulation of BMP and WNT signaling to enhance cardiac differentiation. Moreover, we improve the efficacy of cardiac differentiation by enrichment via lactate. Using our protocol we show efficient derivation of cardiomyocytes from multiple human iPS lines. In particular we demonstrate cardiomyocyte differentiation within 15 days with an efficiency of up to 95 % as judged by flow cytometry staining against cardiac troponin T. Cardiomyocytes derived were functionally validated by alpha-actinin staining, transmission electron microscopy as well as electrophysiological analysis. We expect our protocol to provide a robust basis for scale-up production of functional iPS cell-derived cardiomyocytes that can be used for cell replacement therapy and disease modeling.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Cell Differentiation/physiology , Induced Pluripotent Stem Cells/cytology , Myocytes, Cardiac/cytology , Pluripotent Stem Cells/cytology , Wnt Signaling Pathway/physiology , Action Potentials/physiology , Cell Culture Techniques/methods , Cell Line , Gene Expression , Humans , Induced Pluripotent Stem Cells/metabolism , Induced Pluripotent Stem Cells/ultrastructure , Microscopy, Electron, Transmission , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/ultrastructure , Patch-Clamp Techniques , Pluripotent Stem Cells/metabolism , Pluripotent Stem Cells/ultrastructure , Reverse Transcriptase Polymerase Chain Reaction
5.
Protist ; 163(1): 116-28, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21440496

ABSTRACT

Trophozoites of E. histolytica are equipped with two chagasin-like cysteine protease inhibitors, EhICP1 and EhICP2, also known as amoebiasin 1 and 2. Expression studies using E. invadens as model organism showed that corresponding mRNAs were detectable in both life stages of the parasite, cyst and trophozoite state. Unlike EhICP1 known to act in the cytosol, EhICP2 co-localized with cysteine protease EhCP-A1 in lysosome-like vesicles, as demonstrated by immunofluorescence microscopy. Silencing or overexpressing of the two inhibitors did not show any effect on morphology and viability of the trophozoites. Overexpression of the EhICPs, however, although dramatically dampening the proteolytic activity of cell extracts from the corresponding cell lines, did not influence expression rate or localization of the major amoebic cysteine proteases as well as phagocytosis and digestion of erythrocytes. Activity gels of cell extracts from strains overexpressing ehicp1 showed a drastically reduced activity of EhCP-A1 suggesting a high affinity of EhICP1 towards this protease. From these data, we propose that EhCP-A1 accidentally released into the cytosol is the main target of EhICP1, whereas EhICP2, beside its role in house-keeping processes, may control the proteolytic processing of other hydrolases or fulfils other tasks different from protease inhibition.


Subject(s)
Cysteine Proteases/metabolism , Cysteine Proteinase Inhibitors/metabolism , Entamoeba histolytica/growth & development , Entamoeba histolytica/metabolism , Entamoebiasis/parasitology , Protozoan Proteins/metabolism , Trophozoites/metabolism , Amino Acid Sequence , Cysteine Proteases/genetics , Cysteine Proteinase Inhibitors/chemistry , Cysteine Proteinase Inhibitors/genetics , Entamoeba histolytica/enzymology , Entamoeba histolytica/genetics , Gene Expression Regulation, Developmental , Humans , Molecular Sequence Data , Protein Transport , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Sequence Alignment , Trophozoites/enzymology , Trophozoites/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...